Trial Profile
A Study to Evaluate the Effectiveness and Safety of Adalimumab in Children With Crohn's Disease Who Experienced Infliximab Failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- 25 May 2016 New trial record